A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
about
MicroRNA in rectal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerNon-coding landscapes of colorectal cancerPredictive Biomarkers to Chemoradiation in Locally Advanced Rectal CancerAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsElevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Novel Epigenetic CREB-miR-630 Signaling Axis Regulates Radiosensitivity in Colorectal CancerMicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer.Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating RbDetection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic BiomarkersA functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patientsCircadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerCarcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgerymiR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancerPrognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.Identification of serum microRNA profiles in colon cancermiR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyThe expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma.miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?Implications of the histological determination of microRNAs in the screening, diagnosis and prognosis of colorectal cancer.Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy.Oncogenes associated with drug resistance in ovarian cancer.A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
P2860
Q26748754-244DC5BA-DE60-43F7-B481-5F9FC6417D33Q26775610-B7C6FC1D-7668-461B-B321-60D60E8AE1BCQ26778014-3935A915-A90B-46A4-88D8-292584837D32Q26778557-A24F445F-175A-4BD0-948D-9E98AD5CFB09Q27024427-7DCB32C1-F9C7-4FBA-944A-B2DE4B3E187CQ33670486-CD1E4C89-700C-4533-9637-4BECCDC6EAC0Q34432882-72F6065B-BA66-4817-B1AD-F63C762CE5A4Q34473018-17D93364-3F4B-4661-AB57-BAEAC7B40D11Q34787505-42DF0B0E-6D04-4DE5-8518-77DB67591751Q35106877-2DD84B50-96FC-4EE9-AAC2-944AE86F8C64Q35742738-D872F344-D680-4DF9-8EE3-02032421CF0EQ35944089-FD8531AB-D834-4910-B226-E5E404B47DEFQ36040119-D1D28102-A8BE-4BF9-B3DC-3AE04DA2059BQ36140693-46528763-FE5D-48C3-9400-1381D94FD802Q36204131-2E2C1B83-2278-49AD-988B-474E11662A4DQ36211293-EBEBB998-F0A5-4836-9517-855A457DD36AQ36261585-7056DAB9-FC30-4A3A-BF49-588CC72FC87BQ36480448-8390DFD3-3CE9-48FA-BC93-8E71A7B084DFQ36544900-973E5AED-9822-4437-BE1E-62DCDA535D1BQ36691048-B0FAAB89-4CC6-48AD-A717-920DFB8F5BD2Q36729390-E2CAFA30-1A69-4506-93D7-BAE0C362645AQ36847230-A66D16B1-38E4-4C4C-955D-2A9FF592FB3CQ36889636-AE2687FB-3EF4-4730-9F36-E434EB412F04Q36900550-EF7F3DBB-AEA4-4073-ADAC-75CE8A39B9D4Q37106318-44EB0F4C-D5EA-41B8-80F5-B468BB6A67C1Q37211907-B8B9CF03-38D0-40D5-BA5E-4B06C2FA691AQ37601296-C5A5E878-FD0E-4FA5-BBA9-B33583902217Q37665639-8F8B892E-1C76-4677-89F5-7626116B355FQ37709253-0BE465C1-D2DD-4C91-833B-14A691041BB6Q37735611-A734A7C4-FC4A-48AC-A6F7-85C54C60C425Q38059508-45E49271-60A7-4A16-AB5F-21B6A79ECF56Q38100978-3C13A589-9134-4848-9293-B7E9B3727C84Q38216239-9C4E742D-873D-4C6B-AB16-020971505376Q38226577-F5AC1DA2-4C53-487A-A232-19637093550DQ38432397-0B1168A2-EFF3-46B9-B8AC-5C6A7D069CC3Q38441043-8085F21C-2726-4502-B443-037B01BB5687Q38545768-7CAD187C-DFF7-4A25-8F32-F8E752E3533FQ38552402-79DFE640-F8E0-46CD-AF40-DEAED389BB71Q38594617-C9747E72-FE65-46B9-84FD-15D804E9BAACQ38623990-2883C435-703F-40AF-A03A-364D1D6F1AED
P2860
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@ast
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@en
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@nl
type
label
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@ast
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@en
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@nl
prefLabel
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@ast
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@en
A specific miRNA signature cor ...... ocally advanced rectal cancer.
@nl
P2093
P50
P1476
A specific miRNA signature cor ...... locally advanced rectal cancer
@en
P2093
Chiara Carlomagno
Francesca Falcetta
Sabino De Placido
Stefano Pepe
Vijay Kumar Singh
P304
P356
10.1016/J.IJROBP.2011.09.030
P407
P50
P577
2011-12-13T00:00:00Z